Lineage Cell Therapeutics In shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $145k | 110k | 1.31 |
| 2024-06-30 | $78k | 78k | 1.00 |
| 2023-12-31 | $75k | 69k | 1.09 |
| 2023-09-30 | $81k | 69k | 1.18 |
| 2023-06-30 | $97k | 69k | 1.41 |
| 2021-12-31 | $121k | 49k | 2.45 |
| 2021-09-30 | $42k | 17k | 2.53 |
| 2021-06-30 | $144k | 51k | 2.85 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors